Full length articleA double-network poly(Nɛ-acryloyl l-lysine)/hyaluronic acid hydrogel as a mimic of the breast tumor microenvironment
Graphical abstract
Introduction
Breast cancer is the second leading cause of death after lung cancer in women worldwide, and about one in eight women will develop metastatic breast cancer in their lifetime [1]. However, the current first-line treatment drugs have their inherent shortcomings [2], and the development of new anticancer drugs is being hindered by the lack of effective tumor models that closely mimic the human disease [3]. Researchers have long relied on two-dimensional (2D) in vitro cell culture systems to study cancer cells [4], but they often fail to mimic the natural tumor microenvironment such as cell–cell communication and cell-extracellular matrix (ECM) interactions which play a key role in controlling cancer cell growth and function [5], [6]. In the case of 2D cultures, cells are forced to adopt a planar morphology [7], which alters cell proliferation, migration and invasion, and anti-apoptosis [8], [9]. As a result, cells generally display a dramatically reduced malignant phenotype when compared to the tumor in vivo [10]. Therefore, the traditional 2D cell cultures cannot ideally represent in vivo physiological conditions [11].
To overcome these limitations, three-dimensional (3D) culture systems are now increasingly developed for the tumor engineering [12], [13]. In 3D cultures, cells are often embedded within a matrix material that can mimic the tumor microenvironment (TME), where they can migrate and experience cell-matrix interactions and cell–cell contacts in all directions. Some studies have shown that the tumor cells grown in 3D cultures tend to develop the morphologies and phenotypes observed in vivo [14], [15], [16], display higher aggressiveness, overexpress pro-angiogenic growth factors and acquire increased drug resistance relative to the cells in 2D cultures [17], [18]. However, how to design and build a reasonable 3D culture model for tumor engineering is still a big challenge. An ideal 3D model (matrix) should possess the following characteristics: excellent biocompatibility, good mechanical properties matching with the tumor tissue, easy separation of the cells from the matrix, similar microstructure and chemical components to the tumor tissue, controllable degradability, favorable nutrient exchange, controlled release of bioactive substances, and allowing the vascularization of matrix in vivo. The well-designed 3D tumor co-culture models have been used for understanding tumorigenesis and the high throughput screening of novel drugs [19], [20]. In recent years, both animal-source polymers (e.g. Matrigel [21], collagen [10] and soft salmon fibrin [22]) and synthetic polymers (e.g. poly(lactic-co-glycolic acid) [16], poly(ethylene glycol) diacrylate [23]) have been used to create matrix-derived 3D tumor models. These 3D models have the potential to increase cancer cell malignancy and retain the in vivo phenotype. However, these animal-source materials can potentially transmit pathogens [24], and the synthetic materials are physiologically irrelevant [25] and can release degradation products that are toxic to cells. Therefore, these materials have limited applications in vitro tumor engineering.
Hyaluronic acid (HA) has been used for the construction of 3D tumor models due to its biodegradable, non-immunogenic and non-inflammatory characteristics. HA is not only a structural component in the tumor ECM but also a biologically active molecule that can promote tumor progression through cell signaling [26]. Additionally, HA protects tumor tissues against immune surveillance and chemotherapeutic agents [27]. These unique properties make HA an ideal matrix to prepare 3D tumor models. However, classic HA hydrogels with a single cross-linked network lack structural integrity that may lead to poor mechanical properties [28]. Some researchers have developed a few methods to strengthen HA hydrogels. For example, rigid inorganic nanoparticles such as silica [29] and hydroxyapatite [30] were employed to fill HA hydrogels. However, these nanoparticles are non-degradable or cytotoxic [31], [32]. Recently, the fabrication of double-network hydrogels is recognized as a promising method for strengthening hydrogels [33], [34]. On the other hand, it is known that poly-l-lysine (PLL), as a widely used cationic polymer, has an outstanding ability to promote cell attachment through electrostatic interactions [35]. Given that poly(Nɛ-acryloyl l-lysine) (pLysAAm) and PLL have a similar chemical structure, they would share similar properties. Based on this hypothesis, a photo-crosslinked pLysAAm network was synthesized and used to modify HA hydrogel to create a more biomimetic microenvironment for breast tumor engineering. To our best knowledge, HA-based double-network hydrogels have not been used to fabricate 3D tumor models.
Here, we describe for the first time the preparation and in vitro biocompatibility of novel breast cancer TME-mimicking double-network pLysAAm/HA hydrogels. The double-network hydrogels were synthesized via a two-step photo-polymerization process. The effects of the degree of methacrylation of HA on the morphology, viscoelasticity, swelling and degradation properties of the pLysAAm/HA hydrogel were studied. In the present study, human breast cancer MCF-7 cells were chosen as model cells, since they have been proved to be responsive to 3D environment and extensively used in 3D in vitro breast cancer models [10], [36], [37]. The attachment, growth and function of MCF-7 cells in pLysAAm/HA hydrogels, including proliferation, morphology, migration, invasion and the secretion of pro-angiogenic growth factors VEGF, IL-8 and bFGF, were examined in vitro. In vivo tumorigenesis was also assessed by using xenograft formation in athymic nude mice. The results demonstrated that the MCF-7 cells cultured in 3D pLysAAm/HA hydrogel displayed a more malignant phenotype than those in traditional 2D cultures, indicating that the hydrogel is a promising matrix for the development of physiologically relevant in vitro 3D breast cancer models.
Section snippets
Materials
Hyaluronic acid (HA, molecular weight: 300 kDa), l-lysine hydrochloride, l-cystine dihydrochloride, acryloyl chloride, cystamine dihydrochloride (Cys·2HCl), N-hydroxysuccinimide (NHS) and glutathione (GSH) were purchased from Aladdin Reagent Inc. (Shanghai, China). Glycidyl methacrylate (GMA), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC·HCl), fluorescein isothiocyanate labeled phalloidin (Phalloidin-FITC), 2-hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone (Irgacure
Synthesis of double-network pLysAAm/HA hydrogels
Novel reduction-responsive double-network pLysAAm/HA hydrogels were prepared by a two-step photo-polymerization process (as shown in Fig. 1). The double-network hydrogels were prepared with HA-Cys-GMA chains as the first network and pLysAAm chains as the second network. The HA networks were synthesized via the photo-polymerization of HA-Cys-GMA macromolecules with different degrees of methacrylation in water, using Irgacure 2959 as initiator. HA-Cys-GMA was obtained by the sequent grafting
Conclusions
Novel pLysAAm/HA hydrogels were fabricated by successive photo-polymerization to mimick the ECM of breast tumors. The pLysAAm/HA hydrogels displayed a double-network structure and had controllable mechanical properties, swelling ratio and degradation behavior by adjusting the degree of methacrylation of HA. The hydrogels had good biocompatibility and could support the attachment, proliferation and growth of breast cancer MCF-7 cells. Compared with traditional 2D cell cultures, the MCF-7 cells
Acknowledgements
The authors gratefully acknowledge financial support from the National Natural Science Foundation of China (50603020 and 50773062), the Project of Natural Science Foundation of Shaanxi Province, China (2013K09-27) and the Fundamental Research Funds for the Central Universities (XJJ2014124 and XJJ2013130).
References (80)
- et al.
PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy
Biomaterials
(2014) - et al.
Enzymatically degradable poly(ethylene glycol) hydrogels for the 3D culture and release of human embryonic stem cell derived pancreatic precursor cell aggregates
Acta Biomater.
(2015) - et al.
Multi-parametric hydrogels support 3D in vitro bioengineered microenvironment models of tumor angiogenesis
Biomaterials
(2015) - et al.
In vitro cell migration and invasion assays
Mutat. Res.
(2013) - et al.
Potential effect of matrix stiffness on the enrichment of tumor initiating cells under three-dimensional culture conditions
Exp. Cell Res.
(2015) - et al.
Proliferation and enrichment of CD133+ glioblastoma cancer stem cells on 3D chitosan-alginate scaffolds
Biomaterials
(2014) - et al.
The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs
Biomaterials
(2012) - et al.
Hydrogels to model 3D in vitro microenvironment of tumor vascularization
Adv. Drug Deliv. Rev.
(2014) - et al.
Modeling tissue morphogenesis and cancer in 3D
Cell
(2007) - et al.
A complex 3D human tissue culture system based on mammary stromal cells and silk scaffolds for modeling breast morphogenesis and function
Biomaterials
(2010)
Controlled 3D culture in Matrigel microbeads to analyze clonal acinar development
Biomaterials
Design of cell-matrix interactions in hyaluronic acid hydrogel scaffolds
Acta Biomater.
Biomineralized biomimetic organic/inorganic hybrid hydrogels based on hyaluronic acid and poloxamer
Carbohydr. Polym.
Self-reinforcement and protein sustained delivery of hyaluronan hydrogel by tailoring a dually cross-linked network
Mater. Sci. Eng. C Mater. Biol. Appl.
3D in vitro bioengineered tumors based on collagen I hydrogels
Biomaterials
Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel
Biomaterials
Preparation of porous polymer monoliths featuring enhanced surface coverage with gold nanoparticles
J. Chromatogr. A
Dextran and hyaluronan methacrylate based hydrogels as matrices for soft tissue reconstruction
Biomol. Eng.
Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: high drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity
J. Control. Release
Cytocompatible in situ forming chitosan/hyaluronan hydrogels via a metal-free click chemistry for soft tissue engineering
Acta Biomater.
Cell-laden microengineered gelatin methacrylate hydrogels
Biomaterials
Recreating the tumor microenvironment in a bilayer, hyaluronic acid hydrogel construct for the growth of prostate cancer spheroids
Biomaterials
Reversible disulphide formation in polymer networks: a versatile functional group from synthesis to applications
Eur. Polym. J.
Hyaluronic acid hydrogel scaffolds with a triple degradation behavior for bone tissue engineering
Carbohydr. Polym.
Functional hyaluronic acid hydrogels prepared by a novel method
Mater. Sci. Eng. C Mater. Biol. Appl.
In situ forming hydrogels of hyaluronic acid and inulin derivatives for cartilage regeneration
Carbohydr. Polym.
Engineering a biomimetic three-dimensional nanostructured bone model for breast cancer bone metastasis study
Acta Biomater.
Promotion of cell adhesion by low-molecular-weight hydrogel by Lys based amphiphile
Mater. Sci. Eng. C Mater. Biol. Appl.
CD44 regulates cell proliferation, migration, and invasion via modulation of c-Src transcription in human breast cancer cells
Cell. Signal.
Engineering a scaffold free 3D tumor model for in vitro drug penetration studies
Biomaterials
Mechanics of the F-actin cytoskeleton
J. Biomech.
The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression
Mol. Oncol.
Hallmarks of cancer: the next generation
Cell
A cell-instructive hydrogel to regulate malignancy of 3D tumor spheroids with matrix rigidity
Biomaterials
Regulation of glioma cell phenotype in 3D matrices by hyaluronic acid
Biomaterials
Cancer Facts & Figures 2015
Is anticancer drug development heading in the right direction
Cancer Res.
Biomaterials offer cancer research the third dimension
Nat. Mater.
Characterization of primary breast carcinomas grown in three-dimensional cultures
J. Surg. Res.
Expansion of breast cancer stem cells with fibrous scaffolds
Integr. Biol.
Cited by (43)
HYDRHA: Hydrogels of hyaluronic acid. New biomedical approaches in cancer, neurodegenerative diseases, and tissue engineering
2022, Materials Today BioCitation Excerpt :Dual crosslinking of 3D HA-based hydrogels with tunable elastic modulus were also reported [125,126]. For instance, Skardal et al. fabricated HA-based hydrogels with varying stiffness, dynamically tuning the crosslinker with linear PEGDA and 4-arm PEGDA [119]. They reported that encapsulated cells with aberrant EGFR expression increased their proliferation in stiffer environments showing that targeting the tumor microenvironment extracellular matrix rather than cells, might aid to slow or prevent the progression of GBM tumors.
Mimicking the Natural Basement Membrane for Advanced Tissue Engineering
2022, BiomacromoleculesEngineered in vitro models: Mimicking in vivo physiology
2022, Biomedical Product and Materials Evaluation: Standards and EthicsHydroxyethyl chitosan hydrogels for enhancing breast cancer cell tumorigenesis
2021, International Journal of Biological MacromoleculesCitation Excerpt :Additionally, the morphology of HECS hydrogels did not significantly depend on the amount of crosslinker AHA. This is in accordance with the reported results [35]. Generally, both freeze-drying process and concentration of polymer solution determine the microstructure of lyophilized hydrogel samples [36].
Neutrally charged self-assembling peptide hydrogel recapitulates in vitro mechanisms of breast cancer progression
2021, Materials Science and Engineering C